Evidence map›Paper›PMID 38785978›Full record

ArticleBiomolecules2024

Hypermethylation of the Gene Body in

Hsieh-Tsung Shen, Chin-Sheng Hung, Clilia Davis, Chih-Ming Su, Li-Min Liao, Hsiu-Ming Shih, Kuan-Der Lee, Muhamad Ansar, Ruo-Kai Lin

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hsieh-Tsung ShenThe Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 110301, Taiwan.
Chin-Sheng HungEG BioMed US Inc., Covina, CA 91722, USA.ORCID 0000-0002-9515-2036
Clilia DavisInternational Master Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.ORCID 0009-0004-6773-169X
Chih-Ming SuDepartment of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.
Li-Min LiaoDivision of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235041, Taiwan.
Hsiu-Ming ShihThe Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 110301, Taiwan.
Kuan-Der LeeThe Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 110301, Taiwan.
Muhamad AnsarPh.D. Program in the Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei 110301, Taiwan.
Ruo-Kai LinThe Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 110301, Taiwan.ORCID 0000-0002-5153-0824

Funding

National Science and Technology Council NSC 112-2321-B-038-005
6 · The paper itself

Abstract

Breast cancer is a leading cause of cancer mortality in women worldwide. Using the Infinium MethylationEPIC BeadChip, we analyzed plasma sample methylation to identify the

Indexed as

Adaptor Proteins, Vesicular TransportBiomarkers, TumorBreast NeoplasmsCell ProliferationDNA MethylationCell Line, TumorEarly Detection of CancerFemaleGene Expression Regulation, NeoplasticHumansPrognosisAdaptor Proteins, Vesicular TransportBiomarkers, TumorSRCIN1 protein, humanbiomarkerbreast cancercirculating cell-free DNADNA methylationRNA-seqSRCIN1

Identifiers

PMID38785978
PMCPMC11118508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.